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Structural studies suggest rearrangement of the RNA-binding and catalytic domains of human
mitochondrial PheRS (mtPheRS) is required for aminoacylation. Crosslinking the catalytic and
RNA-binding domains resulted in a ‘‘closed” form of mtPheRS that still catalyzed ATP-dependent
Phe activation, but was no longer able to transfer Phe to tRNA and complete the aminoacylation
reaction. SAXS experiments indicated the presence of both the closed and open forms of mtPheRS
in solution. Together, these results indicate that conformational ﬂexibility of the two functional
modules in mtPheRS is essential for its phenylalanylation activity. This is consistent with the evolu-
tion of the aminoacyl-tRNA synthetases as modular enzymes consisting of separate domains that
display independent activities.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction sible for aa-AMP synthesis, and RNA recognition elements are pres-Aminoacyl-tRNA synthetases (aaRSs) play a key role in main-
taining translational ﬁdelity by synthesizing correctly paired ami-
noacyl-tRNAs (aa-tRNAs) [1,2]. Aminoacyl-tRNA synthesis occurs
in two steps: (i) amino acid activation forming aminoacyl-adenyl-
ate (aa-AMP) and (ii) transfer of amino acid to the 30 end of cognate
tRNA. While some aaRSs are highly selective for their substrate
amino acids, others require a correctionmechanism called ‘‘editing”
to eliminate the incorrect products [3,4]. AaRSs are divided into two
mutually exclusive groups, class I and class II, based on their struc-
ture and function [5–7]. Class I aaRSs are usually monomeric,
whereas class II aaRSs mostly function as dimers or tetramers. A
common feature of all aaRS enzymes is the modular arrangement
of functional units along the sequence [8]. For example, in class I
and class IIc aaRSs the N-terminal half is a catalytic domain respon-chemical Societies. Published by E
se; mtPheRS, mitochondrial
ng domain
Microbiology and Center for
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(M. Safro), ibba.1@osu.eduent in the C-terminal region. It is believed that the catalytic domain
constitutes the ancestral core enzyme to which several accessory
domains including sequences important for RNA recognition, oligo-
merization, assembly and complex formation have been appended
later in evolution [9].
Phenylalanyl-tRNA synthetase (PheRS), a class IIc aaRS, exists as
an (ab)2 heterotetramer in the bacterial [10] and eukaryal cytosolic
forms [11], where the a subunit constitutes the catalytic module
and the B3/B4 domain of the b subunit forms the editing site
[12,13]. PheRS is instead active as a monomer in the organelles
of eukaryotes [14,15] and lacks an editing function [16]. Human
mitochondrial PheRS (mtPheRS) is highly homologous to the corre-
sponding domains of bacterial PheRS, consisting of an N-terminal
catalytic a domain fused to a C-terminal B8-like anticodon-binding
domain (ABD) from the b subunit [17]. The crystal structure of
mtPheRS revealed a fully closed conformation in which the antico-
don-binding domain, located at the C-terminus, overlaps with the
acceptor stem of tRNAPhe when the substrate is modeled in a
position similar to that seen in the bacterial heterotetrameric
PheRS–tRNAPhe complex (see [17] for a complete docking model).
To bind tRNAPhe correctly, the ABD must undergo a 160 hinge-
type rotation upon tRNA binding [17]. MtPheRS is therefore
proposed to exist in two conformations: a ‘‘closed” state when itlsevier B.V. All rights reserved.
S.S. Yadavalli et al. / FEBS Letters 583 (2009) 3204–3208 3205is not bound to the tRNA and an ‘‘open” state upon tRNA binding.
To test this hypothesis, we restrained the movement of the ABD
relative to the catalytic domain, which led to a loss in aminoacyla-
tion but not Phe activation. SAXS analysis conﬁrmed the existence
of the open and closed states in solution, underscoring the impor-
tance of conformational mobility in mtPheRS for maintaining the
function of this essential housekeeping enzyme.Fig. 1. SDS–PAGE analysis of puriﬁed human mtPheRS. WT and mutant mtPheRS
samples were analyzed on a 4–15% (w/v) polyacrylamide gradient gel and the
proteins were visualized by staining with Coomassie blue. Lanes 1 and 2 show WT
and K33C/T351C mtPheRSs, respectively, in the presence of 10 mM DTT. Lanes 3
and 4 represent WT and K33C/T351C mtPheRSs under non-reducing conditions. M
stands for molecular weight marker.2. Materials and methods
2.1. Protein expression, puriﬁcation and characterization
Escherichia coli strain BL21 (pArgU218)/pET21c-PheRS express-
ing C-terminal His6-tagged mtPheRS was a gift from Dr. L. Spre-
mulli (University of North Carolina, Chapel Hill, NC). Primers
were obtained from IDT (Integrated DNA Technologies). Rosetta
(DE3) cells containing pRARE plasmids encoding tRNAs for rare co-
dons were transformed with the mutant mtPheRS plasmid con-
struct and selected on medium containing both ampicillin and
chloramphenicol. The cells were grown at 37 C to OD = 0.8 and in-
duced with 0.5 mM IPTG for 4 h. Cells were harvested, sonicated
and supernatant was collected after centrifugation at 25 000g
for 1 h. The supernatant was applied to a TALONmetal afﬁnity re-
sin column (Clontech), followed by washing and the protein was
eluted with 25 mM Tris–HCl, pH 8.0, 300 mM NaCl, 250 mM imid-
azole and 10% glycerol. Fractions containing mtPheRS were
checked for electrophoretic purity by SDS–PAGE, pooled and dia-
lyzed overnight at 4 C in 50 mM Tris–HCl, pH 7.5, 5 mM MgCl2
and 100 mM KCl. The puriﬁed enzyme was concentrated, adjusted
to 50% (v/v) glycerol and aliquots were stored at 80 C. The pres-
ence of disulﬁde bonds in K33C/T351C mtPheRS was determined
by non-reducing SDS–PAGE. Samples were mixed with a loading
buffer containing 100 mM Tris–HCl, pH 6.8, 10% (v/v) glycerol, 2%
(w/v) SDS, 0.05% (w/v) bromophenol blue and 10 mM DTT (for re-
duced samples only) before electrophoresis. The proteins were re-
solved with a 4–15% pre-cast polyacrylamide gel (Bio-Rad) and
visualized using coomassie blue staining. Aminoacylation and ac-
tive site titration assays were performed as previously described
[18,19].
2.2. Fluorescence intensity measurements and tRNA binding
2AP-labeled E. coli tRNAPhe was synthesized as described previ-
ously [20]. Different concentrations of WT and mutant mtPheRS
were allowed to equilibrate with 0.1 lM 2AP-tRNAPhe in 0.1 M Tris,
pH 7.5, for 15 min. Fluorescence intensities of protein–tRNA com-
plexes were measured using a Fluorolog-3 spectraﬂuorimeter
(Horiba Jobin Yvon). From the ﬂuorescence intensity curves, area
under the curve (AUC) was determined. The percentage increase
in AUC with increase in protein concentration was then compared.
2.3. Small angle X-ray scattering (SAXS)
Synchrotron small angle X-ray scattering data were collected at
the bending magnet beamline X33 (DORIS III storage ring, DESY) of
the EMBL Hamburg Outstation using a pixel detector PILATUS 1 M
(DECTRIS, Switzerland). To monitor for radiation damage, four
successive 30 s exposures of the same sample were done and no
changes were detected. The sample-to-detector distance was
2.7 m providing the range of scattering vectors 0.08 < s < 6 nm1
(s = 4psin h/k, where 2h is the scattering angle and k = 0.15 nm is
the X-ray wavelength). Solutions of mtPheRS alone and its complex
with tRNA were measured at three different concentrations of
mtPheRS in the range from 1 to 5 mg/ml (sample temperature
10 C). The data were processed following standard proceduresusing PRIMUS [21] and GNOM [22], and calibrated against a
reference solution of bovine serum albumin (MM = 66 kDa) to
determine the overall parameters (molecular mass, radius of gyra-
tion Rg, and maximal diameter Dmax). The estimation of excluded
volume Vex and low-resolution ab initio models of mtPheRS solutes
were obtained using DAMMIF [23,24]. This program builds a com-
pact interconnected bead model ﬁtting the experimental data
Iexp(s) to minimize discrepancy:
v2 ¼ 1
N  1
X
j
IexpðsjÞ  cIcalcðsjÞ
rðsjÞ
 2
;
where N is the number of experimental points, c is a scaling factor
and Icalc(s) and r(sj) are the calculated intensity and the experimen-
tal error at the momentum transfer sj, respectively. The scattering
patterns from the atomic models were computed by CRYSOL [25].
The volume fractions of mtPheRS–tRNA complex and free tRNA as
well as ﬁtting to the measured SAXS data were computed using OLI-
GOMER [21].
3. Results
3.1. Catalytic activity of open and closed mtPheRS
Residues K33 and T351 of mtPheRS are separated by 5 Å, and
were both replaced by cysteines to allow disulﬁde bond formation
and subsequent crosslinking of the enzyme in a closed form. Wild-
type (WT) and K33C/T351C mtPheRS samples were subjected to
electrophoresis under reducing and non-reducing conditions
(Fig. 1). Both the samples migrated to a similar extent when
10 mMDTT (reducing conditions) was included in the sample load-
ing buffer (lanes 1 and 2; monomeric mtPheRS, 48 kDa) while
K33C/T351C mtPheRS migrated differently (lane 4) compared to
WT (lane 3) under non-reducing conditions. The faster migration
of the mutant is consistent with the formation of an intramolecular
disulﬁde bond between the two cysteines at positions 33 and 351.
In addition, intermolecular disulﬁde bond formation was observed
in both the WT as well as double cysteine mutant mtPheRSs, form-
ing dimers of 96 kDa. This is expected considering the presence of
six cysteines in WT mtPheRS. None of these six cysteines are in
proximity to each other or to the newly introduced cysteine resi-
dues at positions 33 and 351, ruling out the possibility of the for-
mation of other intramolecular disulﬁde bonds. Additionally,
titration of the free thiols using Ellman’s reagent, 5,50-dithiobis-
2-nitrobenzoic acid (DTNB) or 4,40-dithiopyridine (DTDP) con-
ﬁrmed the presence of equal numbers of reactive thiol groups in
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Fig. 2. Formation of PheRS:Phe-AMP complex. Phenylalanyl–adenylate complex
formation by WT (d) and K33C/T351C (j) mtPheRSs.
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Fig. 3. tRNAPhe binding and aminoacylation. Phenylalanylation by mtPheRSs
(0.4 lM) in the absence of any reducing agents (A), and in the presence of 10 mM
DTT (B). (C) binding of tRNAPhe to mtPheRS. WT (d) and K33C/T351C (j) mtPheRS
under non-reducing conditions.
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(data not shown).
WT and mutant mtPheRSs were tested for their ability to cata-
lyze the ﬁrst step in aminoacylation, the formation of enzyme-
bound aa-AMP, in the absence of reducing agents. Time courses
for PheRS-Phe-AMP formation were monitored using the active site
titration protocol. The closed form of the K33C/T351C mutant was
able to form stable enzyme Phe-AMP complexes at approximately
60% of the level shown by WT mtPheRS under the same conditions
(Fig. 2). These data indicate that the ﬁrst step of the Phe-tRNA
synthesis pathway, Phe-AMP formation, is not dependent on the
conformational state of mtPheRS. Next we investigated the ability
of open and closed mtPheRS to catalyze the second step of the
aminoacylation reaction by monitoring Phe-tRNA accumulation.
Aminoacylation assays performed under non-reducing conditions
suggest that K33C/T351C mtPheRS has negligible activity com-
pared to WT when it is restrained in the closed conformation
(Fig. 3A). Addition of 10 mM DTT to the aminoacylation reaction,
which allows K33C/T351C mtPheRS to adopt an open conforma-
tion, increased Phe-tRNA synthesis by the mutant to approxi-
mately 90% of WT level (Fig. 3B), indicating that conformational
ﬂexibility of functional domains is essential for the aminoacylation
activity of mtPheRS.
3.2. tRNA binding by mtPheRS
It is possible that either the closed form of K33C/T351C
mtPheRS is unable to bind tRNAPhe or that binding does not result
in the correct conformational change necessary for tRNAPhe amino-
acylation. In order to test these two possibilities, we attempted to
measure binding constants for tRNAPhe using ﬂuorescence tech-
niques. It has been estimated previously that mtPheRS has a Km
for tRNAPhe of 18 lM [15] which, given the low yields of active
mitochondrial tRNAPhe transcribed in vitro, precludes accurate
determination of binding constants. Comparison of binding at
sub-saturating non-reducing concentrations suggests that WT
mtPheRS binds tRNAPhe better than the closed mutant form
(Fig. 3C), consistent with the proposal that conformational ﬂexibil-
ity is crucial for maintaining the aminoacylation function. The
conformational ﬂexibility in solution of mtPheRS was further
investigated by small angle X-ray scattering (SAXS).
Table 1
Overall structural parameters evaluated from SAXS data.
Sample Rg, nm MMexp, kDa MMcalc, kDa Dmax, nm Vex, nm3 v
MtPheps 3.03 46.4 48.4 10.5 98 1.38
MtPheRs + tRNA 3.12 68.7 71 12.5 80 1.60
Ratio 1.03 1.48 1.47 1.2 0.82 –
Rg, MMexp, Dmax and Vex are the radius of gyration, molecular mass (MM), maximum size, and excluded volume derived from scattering data. MMcalc is the MM calculated from
primary sequence. v values are the discrepancies between experimental data and calculated scattering curves.
Fig. 4. Scattering proﬁles of mtPheRS alone and its complex with tRNA. Experi-
mental SAXS data of mtPheRS alone (curve 1) and the complex (curve 2) are
represented in logarithmic scale by dots with error bars. The ﬁtting curves are
shown by solid lines. Fits obtained from the crystal structures of ‘‘closed” and
‘‘opened” conformations of mtPheRS are shown in (1) as blue and red lines,
respectively. Fit obtained by OLIGOMER for the model of the complex is shown in
(2) as red line. For better visualization the scattering curve of the protein was
multiplied by a factor of 20.
Fig. 5. Rigid body model of mtPheRS in complex with tRNA. MtPheRS is colored red,
anticodon-binding domain of mtPheRS is colored blue and tRNA is shown in green.
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The conformations of mtPheRS both alone and in complex with
tRNA were probed by SAXS. The overall parameters of mtPheRS
and the mtPheRS-tRNAPhe complex are summarized in Table 1.
The experimental scattering curve from native mitPheRS (Fig. 4,
curve 1, scatter) cannot be adequately ﬁtted by the calculated scat-
tering curve from the crystal structure of mtPheRS (PDB code
3cmq.pdb, [17]) showing the discrepancy v = 3.04 (Fig. 4, curve
1, blue line). At the same time, the ﬁt calculated from the proposed
open conformation of mtPheRS [17] provides much better agree-
ment with the experimental data with the discrepancy v = 1.38
(Fig. 4, curve 1, red line). However, smearing of the scattering pro-
ﬁle suggests that the structure in solution may be ﬂexible. Such a
conformational mobility would not be surprising due to the
extended linker region (residues 290–322 in mature mtPheRS),
connecting the catalytic module of the enzyme to the anticodon-
binding domain. These results are indicative of the conformational
ﬂexibility of mtPheRS that exists in solution, and demonstrate that
both the ‘‘crystal” and ‘‘solution forms” are two functionally rele-
vant states.
Given that the solution of the complex contained excess tRNA,
no direct modeling of its structure was possible. A set of tentative
models of the complex, which obey the contact conditions, was
generated interactively by MASSHA [26]. The scattering patternsof these models were calculated and taken in a linear combination
with the computed scattering from the tRNA molecule (PDB code
1eiy) to ﬁt the experimental pattern from the complex using OLI-
GOMER. The overall best model (Fig. 5) provides the ﬁt with
v = 1.60 (Fig. 4, curve 2) at the volume fractions of 53% and 47%
for the 1:1 mtPheRS–tRNA complex and free tRNA, respectively.
This model further suggests that the formation of the mtPheRS–
tRNA complex is accompanied by signiﬁcant rearrangement of
the anticodon-binding domain.
4. Discussion
4.1. The open conformation of mtPheRS aminoacylates tRNAPhe
Biochemical data indicate that while the open form of mtPheRS
only binds tRNAPhe moderately more strongly than the closed form,
only the open form is competent in aminoacylation. This is consis-
tent with models of the open form derived from the crystal struc-
ture of mtPheRS, which suggested that accurate binding of tRNA
recognition elements would necessitate a large conformational
rearrangement in the C-terminal anticodon-binding domain. The
use of SAXS to augment existing crystallographic data conﬁrmed
the existence of the open form of mtPheRS, and provided a model
for tRNAPhe recognition. As seen for other class II aaRSs, mtPheRS
3208 S.S. Yadavalli et al. / FEBS Letters 583 (2009) 3204–3208recognizes the major groove side of the acceptor stem (Fig. 5) but
does so via an unusually small contact region with tRNAPhe (74 and
17 protein residues for bacterial and mitochondrial PheRSs, respec-
tively). The majority of the interactions with tRNAPhe are concen-
trated around the anticodon loop and 30-CCA-end, and the
corresponding amino acid sequences are strictly conserved
throughout bacterial and mitochondrial PheRSs and also occupy
similar positions in space. These data indicate that mtPheRS has
only retained the common, evolutionarily conserved, tRNAPhe rec-
ognition domains while losing idiosyncratic structures such as
the B2 RNA-binding domain of bacterial PheRS [27]. This minimal
recognition strategy is consistent with the ability of monomeric
mtPheRS to efﬁciently cross-aminoacylate tRNAPhe from E. coli,
Thermus thermophilus and yeast cytoplasm, a property absent from
(ab)2-type PheRSs (M.S., M.I., unpublished data).
4.2. Evolution of mtPheRS and the modularity of aaRSs
The protein–RNA recognition interface of mtPheRS is consider-
ably smaller than that of its cytoplasmic counterparts, reﬂecting
the loss of several accessory domains during evolution of the
organellar enzyme from its bacterial ancestor [16,28]. This reduc-
tion in the size and complexity of organellar PheRS explains both
the relaxed speciﬁcity of tRNAPhe recognition (above) and the
reliance on a large conformational change to complete aminoacy-
lation. (ab)2-type PheRSs bind tRNA across more than one subunit
[10], while the monomeric mtPheRS instead ensures accurate rec-
ognition and aminoacylation by co-ordinating the movement of
the N- and C-terminal domains, which bind the 30-CCA and antico-
don of tRNA, respectively. These data reveal how conserved mod-
ules can maintain the canonical role of PheRS, Phe-tRNAPhe
synthesis, in different structural contexts despite the presence or
absence of idiosyncratic modules with roles ranging from proof-
reading to DNA-binding [16,29]. AaRSs are believed to have
evolved in a piece-wise fashion where different modules are ar-
ranged along the protein sequence [8]. Our data now show that
the functional independence of such modules ensures canonical
aaRS activity is retained despite the frequent addition or loss of
other secondary activities during evolution. This structural and
evolutionary versatility allows aaRSs to acquire functions outside
protein synthesis, where they have recently been shown to play
numerous key roles [30,31].
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